Related Experiment Video
Updated: Nov 20, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Establishing a clinical high-risk program in Tunisia, North Africa: A pilot study in early detection and
Joseph Ventura1, Lamia Jouini2,3, Amina Aissa2,3
1UCLA Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, USA.
Insights
Early identification of clinical high-risk (CHR) youth is advancing globally. A new program in Tunisia successfully adapted these methods, showing comparable psychosis conversion rates to Western countries.
Area of Science:
- Psychiatry
- Mental Health Research
- Global Health
Background:
- Significant advancements in early identification and prevention strategies for young people at clinical high-risk (CHR) have been achieved.
- However, most established procedures originate from high-income nations, limiting their accessibility in middle-income countries.
- North African nations like Tunisia can greatly benefit from these empirically-based assessment approaches.
Purpose of the Study:
- To establish the first clinical high-risk program (CHiRP) in Tunisia, a middle-income country.
- To adapt and implement structured assessment tools (CAARMS, BPRS, SCID) with high interrater reliability.
- To evaluate the feasibility of screening, assessing, and managing CHR youth in a North African context.
Main Methods:
- Nine Tunisian psychiatric raters received comprehensive training on structured assessments (CAARMS, BPRS, SCID).
- High standards of interrater reliability were achieved (ICC ≥ .80 for CAARMS/BPRS, Kappa ≥ .75 for SCID).
- Ten pilot patients exhibiting potential CHR signs were recruited and evaluated for Attenuated Psychosis Syndrome.
Main Results:
- Trained raters met rigorous interrater reliability criteria for all assessment tools.
- Six out of ten pilot patients were classified as CHR with Attenuated Psychosis.
- One patient converted to psychosis within 3 months, yielding a 17% conversion rate comparable to global benchmarks.
Conclusions:
- The first CHR program has been successfully established in Tunisia, demonstrating the adaptability of high-income country methods.
- Key efforts included assembling a dedicated team, securing administrative support, and achieving high rater reliability.
- The study confirms the feasibility of screening, assessing, treating, and following CHR patients in Tunisia, with outcomes mirroring those in Western and European countries.
Background:
Early identification and prevention research has provided huge advances in our understanding of early screening and identification of young people at clinical high-risk (CHR). Most of these procedures were developed in high-income countries, yet middle-income countries in North Africa such as Tunisia can benefit from these empirically-based assessment approaches.
Methods:
Using established procedures, nine Tunisian psychiatric raters were trained on structured assessments: the CAARMS, BPRS, and SCID to high standards of interrater reliability. These raters developed a clinical high-risk program (CHiRP) in Tunisia and recruited 10 patients who were exhibiting possible signs of CHR. These patients were evaluated to determine if they met criteria for a CHR group, such as Attenuated Psychosis.
Results:
Trained raters met the following interrater reliability criteria for the CAARMS and BPRS (ICC = .80 or greater) and the SCID (Kappa = .75 or greater). Of 10 pilot patients, six were classified as CHR and belonging to the Attenuated Psychosis Group. One of the six patients converted to psychosis 3 months after study entry for a conversion rate of 17% which is comparable with currently published rates globally.
Discussion:
The first CHR program has been established in Tunisia, a middle-income country using methods developed in high income countries. Efforts aimed at assembling a group of prevention-oriented psychiatrists, obtaining administrative support, and training raters to high levels of interrater reliability were successful. The feasibility was demonstrated for screening, assessing, treating, and following-up of 10 CHR patients suggesting that conversion rates are comparable to those of Western and European countries.
More Related Videos
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Preventive Healthcare Services

